Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Meropenem vs Imipenem in Complicated Skin Infections
NCT00619710Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2001
- Primary completion
- Dec 2003
- Modality
- Small Molecules
01
Overview
A Phase 3 trial of meropenem in Skin and Skin Structure Infection (SSSI), sponsored by Pfizer. Started Feb 2001; status: completed.
02
Drugs
meropenem
03
Conditions
Skin and Skin Structure Infection (SSSI)
Beyond the preview
Go deeper on NCT00619710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00619710.